Anixa Biosciences Inc (ANIX) is a Healthcare · Biotechnology company listed on NASDAQ. Price $2.76 (+0.00%), Market cap $0.09B, 52-week low–high $2.50 ~ $5.22.
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company also engaged in the development of a vaccine against breast cancer; and the development of a vaccine discovery program to develop additional cancer vaccines to address intractable cancers, including high incidence malignancies in lung, colon, and prostate. Its vaccine technologies focus on the discovery of additi
Financial statements, price targets, institutional (13F) holdings and related news for Anixa Biosciences Inc are updated in real time on BlackAll Trade.
Anixa Biosciences Inc trades at $2.76 (+0.00%). Real-time quotes and charts are available on BlackAll Trade.
Anixa Biosciences Inc has a market cap of about $0.09B.
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltag